Metabolic Syndrome Ups Major Cardiovascular, Death Risks in CKD
Avoiding even 1 metabolic syndrome component might decrease the risk for a cardiovascular event or premature death, investigators suggest.
Avoiding even 1 metabolic syndrome component might decrease the risk for a cardiovascular event or premature death, investigators suggest.
Here’s what clinicians and patients need to know.
More severe frailty predicted a higher risk of UTIs.
Patients on hemodialysis who have secondary hyperparathyroidism experienced a 40% reduction in PTH levels over 12 months of etelcalcetide treatment, investigators reported.
Study findings indicate a correlation between iPTH and vascular calcification in patients with diabetic kidney disease.
Cardiovascular events are the leading cause of death among patients with chronic kidney disease, and metabolic acidosis in this population is underdiagnosed.
The finding is from the first population-based prevalence study of nocturnal polyuria to include both men and women, according to researchers.
Among the patients with high-risk diabetes in the trial, 21.8% had both a history of cardiovascular disease and current kidney disease.
As erectile dysfunction severity increased, serum folic acid levels decreased, an analysis found.
Weight loss partly accounted for the association between high parathyroid hormone levels and mortality among patients on hemodialysis.